Mouse lymphoid cells

Mouse lymphoid cells represent a heterogeneous population of immune cells in Mus musculus, primarily including T lymphocytes, B lymphocytes, and Natural Killer (NK) cells (Abbas et al., 2021). These cells are the primary mediators of the adaptive immune response, responsible for recognizing specific antigens and executing effector functions such as cytokine production and direct cell lysis (Murphy & Weaver, 2016). In the bone marrow, common lymphoid progenitors give rise to these lineages, which then mature in the thymus or peripheral lymphoid organs (Janeway's Immunobiology, 2016). In the context of drug discovery, mouse lymphoid cells are frequently utilized in preclinical studies to evaluate the immunomodulatory potential of new chemical entities and biologics (The Jackson Laboratory, 2024). They serve as a critical biological system for studying diseases such as lymphoma, leukemia, and various autoimmune disorders (NIH, 2023). However, the term refers to a broad cellular category rather than a specific molecular entity like a receptor, enzyme, or ion channel. Consequently, it is not a valid therapeutic target for structured drug-target interaction data, as it encompasses thousands of potential individual molecular targets. Drugs like cyclosporine or corticosteroids may affect these cells, but they do so by targeting specific proteins within or on the surface of the cells, such as calcineurin or the glucocorticoid receptor (StatPearls, 2023).

Other names

Murine lymphocytesMouse immune cellsMurine lymphoid lineage cells

Not applicable; this is a cell population containing multiple distinct molecular targets rather than a single therapeutic molecule.